LADENBURG THALMANN FINANCIAL SERVICES INC. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 98 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2019$4,000
+33.3%
1380.0%0.00%
Q3 2019$3,000
+50.0%
1380.0%0.00%
Q2 2019$2,000
-33.3%
1380.0%0.00%
Q1 2019$3,0000.0%138
+17.9%
0.00%
Q4 2018$3,000
+200.0%
117
+588.2%
0.00%
Q3 2018$1,000170.0%0.00%
Q2 2018$0170.0%0.00%
Q1 2018$0170.0%0.00%
Q4 2017$0
-100.0%
170.0%0.00%
Q3 2017$1,0000.0%170.0%0.00%
Q2 2017$1,0000.0%170.0%0.00%
Q1 2017$1,0000.0%170.0%0.00%
Q4 2016$1,0000.0%170.0%0.00%
Q3 2016$1,000170.0%0.00%
Q2 2016$0170.0%0.00%
Q1 2016$0170.0%0.00%
Q4 2015$0170.0%0.00%
Q3 2015$017
-34.6%
0.00%
Q2 2015$0260.0%0.00%
Q1 2015$026
+52.9%
0.00%
Q4 2014$0170.0%0.00%
Q3 2014$0170.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q2 2016
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$78,677,17613.94%
Irenic Capital Management LP 1,700,937$19,084,5139.15%
Weiss Asset Management LP 7,457,060$83,668,2133.41%
Newtyn Management, LLC 1,450,000$16,269,0003.36%
Palliser Capital (UK) Ltd 97,100$1,089,4622.65%
Chescapmanager LLC 850,988$9,5482.24%
Park West Asset Management LLC 1,920,324$21,546,0352.11%
Baupost Group 11,419,226$128,1242.09%
Saturn V Capital Management LP 141,339$1,334,3421.11%
Oasis Management Co Ltd. 296,960$3,331,8910.66%
View complete list of THERAVANCE BIOPHARMA INC shareholders